Inpatient management and post-discharge outcomes of hyperkalemia-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Inpatient management and post-discharge outcomes of hyperkalemia

Published:2021-05-26 Issue:4 Volume:49 Page:273-279
ISSN:2154-8331
Container-title:Hospital Practice
language:en
Short-container-title:Hospital Practice

Author:

Davis Jill¹,Israni Rubeen¹,Mu Fan²,Cook Erin E.²^ORCID,Szerlip Harold³,Uwaifo Gabriel⁴,Fonseca Vivian⁵,Betts Keith A.²

Affiliation:

1. AstraZeneca, Wilmington, Delaware, USA

2. Analysis Group, Inc, Boston, Massachusetts, USA

3. Baylor University Medical Center, Dallas, Texas, USA

4. Oschner Medical Center, New Orleans, Louisiana, USA

5. Tulane University Medical Center, Tulane University School of Medicine, New Orleans, Louisiana, USA

Funder

AstraZeneca

Publisher

Informa UK Limited

Subject

General Medicine

Link

https://www.tandfonline.com/doi/pdf/10.1080/21548331.2021.1925554

Reference40 articles.

1. Tailoring treatment of hyperkalemia

2. Hyperkalaemia

3. Elevated Potassium Levels in Patients With Congestive Heart Failure: Occurrence, Risk Factors, and Clinical Outcomes

4. Potassium Homeostasis and Renin-Angiotensin-Aldosterone System Inhibitors

5. Incidence and Predictors of Hyperkalemia in Patients With Heart Failure

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The burden of hyperkalaemia on hospital healthcare resources;Clinical and Experimental Medicine;2024-08-13

2. Outcomes in Older Inpatients with Hyperkalemia: A Follow-up Observational Study;Journal of the Indian Academy of Geriatrics;2024-04

3. Heparin‐induced hyperkalemia, can LMWH cause hyperkalemia? A systematic review;eJHaem;2023-10-03

4. Rationale and design of CONTINUITY: a Phase 4 randomized controlled trial of continued post-discharge sodium zirconium cyclosilicate treatment versus standard of care for hyperkalemia in chronic kidney disease;Clinical Kidney Journal;2023-03-23

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3